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Abstract. Local drug delivery has received much recognition in recent years, yet it is still
unpredictable how drug efficacy depends on physicochemical properties and delivery kinetics.
The purpose of the current study is to provide a useful mathematical model for drug release from
a drug delivery device and consecutive drug transport in biological tissue, thereby aiding the
development of new therapeutic drug by a systemic approach. In order to study the complete
process, a two-layer spatio-temporal model depicting drug transport between the coupled media
is presented. Drug release is described by considering solubilisation dynamics of drug particle,
diffusion of the solubilised drug through porous matrix and also some other processes like
reversible dissociation / recrystallization, drug particle-receptor binding and internalization
phenomena. The model has led to a system of partial differential equations describing the
important properties of drug kinetics. This model contributes towards the perception of the
roles played by diffusion, mass-transfer, particle binding and internalization parameters.
1. Introduction
Studies related to drug delivery draw much attention to present day researchers for their theo-
retical and clinical investigations. The controlled drug delivery is a process by means of which
a drug is delivered at a pre-determined rate, locally or systemically, for a stipulated period of
time. Controlled drug delivery systems may incorporate the maintenance of drug levels within
a desired therapeutic range, the need of less number of administrations, optimal use of the re-
quired drug and yet possibility of enhanced patient compliance. The quintessential drug delivery
should be not only inert, biocompatible, but also at the same time provide patient compliance,
capable of attaining high drug loading. However, it should also have preventive measures for the
accidental release of drug and at the same time it should be simple to administer and to remove
from the body. Controlled release drug delivery involves drug-encapsulating devices from which
drug or therapeutic compounds may be released at controlled rates for prolonged span of time.
While many old and new therapeutics are well tolerated, numerous compounds are in re-
quirement of localized advanced drug delivery technologies to reduce toxicity level, enhance
therapeutic efficacy and potentially recast bio-distribution. Local drug delivery is the mani-
festation of drug delivery in which drugs are delivered at a specific site inside the body to a
particular diseased organ or tissue. Though the drug delivery, in principle, may be monitored,
but the most important hazard is that the design of drug delivery is unclear, which must be
used to attain the level of control required for a specific purpose. This is because there exists
complex interaction between biology, polymer chemistry and pharmacology [1].
Mathematical modelling of drug delivery and predictability of drug release is a steadily grow-
ing field with respect to its importance in academic and industrial areas due to its astronomic
future potential. In the light of drug dose to be incorporated in desired drug administration
and targeted drug release profile, mathematical prognosis will allow for good estimates of the
required composition along with other requirements of the respective drug dosage forms. An
extremely challenging aspect is to combine mathematical theories with models quantifying the
release and transport of drug in living tissues and cells. Various works are done in the past on
drug delivery devices regarding its therapeutic efficiency, optimal design with the aid of either
experimental methods or numerical / modelling simulations and sometimes both procedures are
used [2, 3, 4, 5]. The investigation in which drug association / dissociation aspect is taken into
account with regard to transdermal drug delivery [6] while in another study, drug release process
from a microparticle is considered based on solubilisation dynamics of the drug [7]. Very recently,
the updated mathematical model considering both the above mentioned aspects is framed and
analysed successfully [8].
The study of concern is presented by a phenomenological mathematical model of drug release
from a local drug delivery device and its subsequent transport to the biological tissue. The model
is comprised of two-phase drug release where the drug undergoes solubilisation, recrystallisation
and internalization through a porous membrane. An important aspect of the aforementioned
model is appropriate judgement of the model parameters of significance such as diffusion coef-
ficient, solid-liquid transfer rate, mass-transfer, drug association / dissociation rate constants,
membrane permeability and internalization rate constant. The numerical simulation provides
reliable information on different properties of drug release kinetics.
2. Problem of drug release
To model the local drug delivery device, a two-phase system is considered which is made of: (a)
a polymeric matrix that operates as a reservoir where the drug is loaded initially, and (b) the
biological tissue where the drug is being transported as target region. The first phase i.e the
drug delivery device is framed as a planar slab, encompassed on one side with an impermeable
backing and the other side of the device is in contact with layer (b). A rate-controlling mem-
brane protecting the polymeric matrix is present at the interface of the coupled layers.
2.1. Mechanism of drug release
At the beginning, the drug occurs completely in a solid phase embraced within the polymeric
matrix (e.g. in crystalline form) (C∗0 ) at its maximum concentration. Being in bound state, it
cannot be transferred to the tissues directly. Water enters into the polymeric matrix and wets
the drug encapsulated inside it, permitting solubilisation of the loaded drug crystals into free
state (C0) which diffuses out of the matrix into the tissue. The rate of transfer of drug from
solid state to free state depends not only on solubilisation phenomenon but is also proportional
to the difference between C∗0 and C0. Again, a fraction of solid drug (β0C
∗
0) is transformed to its
free state which is competent to diffuse. Conversely, through a recrystallisation process, another
fraction of free drug (δ0C0) is transferred back to its bound state. Simultaneously, a part of free
drug (C1) diffuses into the tissue. In the similar way, in tissue, a portion of free drug (kaC1)
is metabolised into bound phase (C∗1 ), which also unbinds (kdC
∗
1 ) to form free drug. Now, the
bound drug is engulfed (internalized) (kiC
∗
1 ) by the cell in the tissue through the process of
endocytosis. Endocytosis is an active energy-using transport phenomenon in which molecules
(proteins, drugs etc.) are transported into the cell. Thus, bound drug gets transformed into
internalized drug particles (Ci). These internalized drug particles, after a span of time, gets
degraded by the lysosomes and the drug remnants after degradation (kidCi) is expelled out
of the cell into the extracellular fluid. The complete drug transport process is schematically
demonstrated in Fig. 1.
Figure 1. Schematic diagram of drug transport
3. Formulation of the model
Generally, mass transport prevails in the direction normal to the tissue which may be the reason
behind the modelling restriction confined to one-dimensional case. In the present study, x-axis
is considered to be normal to the layer and aligned with the positive direction outwards.
3.1. Drug dynamics in the polymeric matrix
The governing equations describing the dynamics of drug release in the polymeric matrix phase
are
∂C∗0
∂t
= −α0(Φ0C∗0 − C0)− km(Clim −C0)− β0C∗0 + δ0C0, x ∈ (0, l0) (3.1)
∂C0
∂t
= D0
∂2C0
∂x2
+ α0(Φ0C
∗
0 − C0) + km(Clim −C0) + β0C∗0 − δ0C0, x ∈ (0, l0) (3.2)
where, Φ0(=
kε0
1−ε0
) is the ratio of accessible void volume to solid volume, C∗0 denotes available
molar concentration of solid drug, C0 is the available molar concentration of free drug, k stands
for partition coefficient, ε0 denotes porosity, l0 is the length of the polymeric matrix, km is mass
transfer coefficient, Clim stands for drug solubilisation limit, β0 is the dissociation rate constant,
δ0 is the association rate constant, α0 denotes solid-liquid rate parameter. D0 is the diffusion
coefficient of free drug in the matrix.
3.2. Drug dynamics in the biological tissue
The corresponding equations governing the dynamics of drug in the tissue are
∂C∗1
∂t
= kaC1 − kdC∗1 − kiC∗1 , x ∈ (l0, l1) (3.3)
∂C1
∂t
= D1
∂2C1
∂x2
− kaC1 + kdC∗1 , x ∈ (l0, l1) (3.4)
∂Ci
∂t
= kiC
∗
1 − kidCi, x ∈ (l0, l1) (3.5)
where, C1 is the available molar concentration of free drug in the tissue, C
∗
1 is the available mo-
lar concentration of solid drug in the tissue, Ci denotes the molar concentration of internalized
drug particles, l1− l0 is the length of the tissue, ka depicts the binding rate coefficient, kd is the
dissociation rate coefficient, ki stands for internalization rate coefficient, kid denotes degradation
rate constant in the lysosome, and D1 is the diffusion coefficient of free drug in the biological
tissue.
4. Initial, Interface and Boundary Conditions
The initial conditions are as follows:
C∗0(x, 0) =M , C0(x, 0) = 0, C
∗
1 (x, 0) = 0, C1(x, 0) = 0, Ci(x, 0) = 0.
A flux continuity must be assigned at the interface, i.e at x = l0, −D0 ∂C0∂x = −D1
∂C1
∂x
.
No mass flux can pass to exterior environment due to the presence of impermeable backing
and hence no flux condition arises. At x = 0, D0
∂C0
∂x
= 0.
Lastly, at x = l1, C1(l1, t) is considered to be finite.
5. Model Solutions
For the purpose of reducing the number of model parameters, the entire above-mentioned equa-
tions together with all the conditions are made dimensionless. The transformed equations subject
to the conditions in dimensionless approach are solved analytically by separation of variables
procedure. Thus, the solutions should be read as
C0 = E1(e
−m1t − e−m2t) cos ax (5.1)
C∗0 =
E1(α0 + km + δ0) cos ax
(m1 − (α0Φ0 + β0))(m2 − (α0Φ0 + β0))
[
(m1 − (α0Φ0 + β0))e−m2t − (m2 − (α0Φ0 + β0))
(5.2)
e−m1t + (m2 −m1)e−(α0Φ0+β0)t
]
− kmClim
(α0Φ0 + β0)
[
1− e−(α0Φ0+β0)t
]
+ e−(α0Φ0+β0)t
C1 = E2(e
−n1t − e−n2t) cos bx (5.3)
C∗1 =
E2ka cos bx
(kd + ki − n1)(kd + ki − n2)
[
(kd+ki−n2)e−n1t− (kd+ki−n1)e−n2t+(n2−n1)e−(kd+ki)t
]
(5.4)
Ci =
E2kaki cos bx
(kd + ki − n1)(kd + ki − n2)
[(kd + ki − n2)
(kid − n1)
(e−n1t−e−kidt)−(kd + ki − n1)
(kid − n2)
(e−n2t−e−kidt)+
(5.5)
(n2 − n1)
(kid − kd − ki)
(e−(kd+ki)t − e−kidt)
]
where, E1 and E2 are arbitrary constants to be determined from the prevailing conditions,
m1 =
A−
√
A2 + 4B
2
, m2 =
A+
√
A2 + 4B
2
A = α0(Φ0 + 1) + km + β0 + δ0 − λγ, B = λγ(α0Φ0 + β0), λ = −a2,
n1 =
P −
√
P 2 − 4Q
2
, n2 =
P +
√
P 2 − 4Q
2
P = kd + ki + ka − µ, Q = kika − µ(kd + ki), µ = −b2.
and, a and b are any positive real numbers.
All the parameters and the variables are expressed in dimensionless form whose expressions are
not included here for the sake of brevity.
6. Numerical illustration and discussion
Numerical illustration for the present drug release system is performed by taking various pa-
rameter values of the model in order to characterise the pharmacokinetic aspects. The graphical
representations of the time-variant concentration profiles of the drug in its different states for
both the facets are well illustrated through the Figs. 2 - 6 in order to understand the drug
release phenomenon.
The time-variant concentration profiles for solid (loaded) and free drug particles in the polymeric
matrix phase for four different axial locations spread over the entire domain are demonstrated
in Figs. 2 and 3. The rate of decrease of concentration of loaded drug (C∗0 ) becomes higher
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Figure 2. Time variant concentration profile
of C∗0 at different locations.
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Figure 3. Time variant concentration profile
of C0 at different locations.
and higher as one proceeds away from the commencing region of the polymeric matrix to the
interface resulting in early disappearance. When the loaded drug gets exposed to water, a solid-
liquid mass transfer is initiated causing drug release from the matrix which is on the process of
transformation of free drug C0. One may note on the other hand that C0 grows and acquires
certain peak in accordance to a specific instant of time followed by a gradual descend for rest of
the times.
Figs. 4 - 6 represent the time-variant concentration profiles for free, bound and internalized
drug particles respectively in the biological tissue for different axial locations stretched over the
entire domain. It is important to observe that C1 heightens hastily compared to both C
∗
1 and
Ci towards the inception. This observation, as anticipated, reflects in the realm of drug kinetics
that free drug (C1) gets transformed into bound drug (C
∗
1 ) and subsequently the bound drug is
metabolised into internalized drug (Ci) after a short passage of time. Ultimately, it is further
noted that the internalized drug takes more time to get absorbed completely in the tissue than
the characteristics of both bound and free drug particles. In addition to the present findings,
one may append that the extended time span distinctly reveals that both loaded and free drug
particles in polymeric matrix melt away in a comparatively small span of time than those in the
tissue where they need to take time lengthened to get the drug absorbed completely.
One may also explore a variety of cases in order to exhibit the behaviour of the concentration
profiles for both the phases under present consideration by varying all the parameter values of
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Figure 4. Time variant
concentration profile of C1 at
different locations.
0 10 20 30 40 50 60 70 80
0
1
2
3
4
5
6
x 10−3
time
co
n
ce
n
tra
tio
n 
C 1*
 
 
 
x=0.1
x=0.3
x=0.5
x=0.8
Figure 5. Time variant
concentration profile of C∗1 at
different locations.
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Figure 6. Time variant
concentration profile of Ci at
different locations.
significance. The sensitivity of the model parameters imply the need of the components to be
included in the model formation for future course of studies relevant to this domain.
7. Conclusions
The sensitivity of the model parameters poses challenges to the applicability of drug adminis-
tration for treatment of patients at large through pharmacotherapy. One may highlight that
as both loaded and free drug particles in polymeric matrix melt away in comparatively small
span of time than those in the tissue, its influence will certainly persist for a long time before
repeated medication occurs and hence care needs to be exercised for maintaining appropriate
time-gap before redispensation in order to avoid toxicity by the presence of excess drug.
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